papers

Publications (14)

q-bio.PE2021

Rule-based epidemic models

William Waites, Matteo Cavaliere, David Manheim +2

This paper gives an introduction to rule-based modelling applied to topics in infectious diseases. Rule-based models generalise reaction-based models with reagents that have intern…

cs.AI2025

Limits of Safe AI Deployment: Differentiating Oversight and Control

David Manheim, Aidan Homewood

Oversight and control, which we collectively call supervision, are often discussed as ways to ensure that AI systems are accountable, reliable, and able to fulfill governance and m…

q-bio.PE2021

Compositional modelling of immune response and virus transmission dynamics

William Waites, Matteo Cavaliere, Vincent Danos +7

Transmission models for infectious diseases are typically formulated in terms of dynamics between individuals or groups with processes such as disease progression or recovery for e…

cs.AI2026

Evaluation Cards: An Interpretive Layer for AI Evaluation Reporting

Avijit Ghosh, Anka Reuel, Jenny Chim +45

AI evaluation results are produced at scale but reported inconsistently across leaderboards, model cards, benchmark papers, and company blogs. The cost is interpretive: readers can…

q-bio.BM2022

Molecular and Serologic Diagnostic Technologies for SARS-CoV-2

Halie M. Rando, Christian Brueffer, Ronan Lordan +10

The COVID-19 pandemic has presented many challenges that have spurred biotechnological research to address specific problems. Diagnostics is one area where biotechnology has been c…

cs.CY2020

Forecasting AI Progress: A Research Agenda

Ross Gruetzemacher, Florian Dorner, Niko Bernaola-Alvarez +2

Forecasting AI progress is essential to reducing uncertainty in order to appropriately plan for research efforts on AI safety and AI governance. While this is generally considered…